DMD # 76554
: Pharmacokinetic parameters and hepatic concentration of pazopanib 2.27 ± 0.24* 12.6 ± 2.4* 0.151 ± 0.028* 65.1 ± 34.1 6.51 ± 0.58
a -----------------------------------------------------------------------------------------------------------
Each inhibitor (+) or vehicle alone (-) was administered prior to intravenous injection of pazopanib (0.02 mg/kg) in mice. Plasma concentration of pazopanib was measured for 8 h, and hepatic concentration of pazopanib was measured at 8 h after the injection. Data represent the mean ± SEM (n = 3). b Area under the curve from 0 to 8 h. c Hepatic concentration at 8 h. d Liver-to-plasma concentration ratio at 8h. e Distribution volume to the central compartment. f Half-life in terminal phase. *, Significant difference from vehicle-treated mice (p<0.05).
